EP3137504
Mótefni sem binst við FcRn til meðhöndlunar á sjálfsnæmissjúkdómum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
30.4.2015EP published:
10.5.2023EP application number:
15785500.8
EP translation filed:
10.8.2023Grant published:
15.9.2023EPO information:
European Patent Register
Max expiry date:
29.4.2035Expiry date:
29.4.2026Next due date:
30.4.2026
Title in English:
ANTIBODY BINDING TO FCRN FOR TREATING AUTOIMMUNE DISEASESLanguage of the patent:
English
Timeline
Today
30.4.2015EP application
10.5.2023EP Publication
10.8.2023Translation submitted
15.9.2023Registration published
29.4.2026Expires
Owner
Name:
Hanall Biopharma Co., Ltd.Address:
43 Sangseodang 1-gil Daedeok-gu, Daejeon 306-120, KR
Inventor
Name:
KIM, Sung WukAddress:
Seongnam-si Gyeonggi-do 463-802, KR
Name:
PARK, Seung KookAddress:
Seoul 135-230, KR
Name:
JEONG, Jae KapAddress:
Daejeon 300-040, KR
Name:
AHN, Hyea KyungAddress:
Yongin-si Gyeonggi-do 448-130, KR
Name:
KIM, Min SunAddress:
Suwon-si Gyeonggi-do 443-270, KR
Name:
KIM, Eun SunAddress:
Seoul 135-928, KR
Name:
YONG, Hae-YoungAddress:
Suwon-si Gyeonggi-do 443-727, KR
Name:
SHIN, DongokAddress:
Suwon-si Gyeonggi-do 442-816, KR
Name:
SONG, Yeon JungAddress:
Suwon-si Gyeonggi-do 442-826, KR
Name:
YOO, Tae HyoungAddress:
Yongin-si Gyeonggi-do 446-588, KR
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201461986742 PDate:
30.4.2014Country:
US
Classification
Categories:
C07K 16/28, G01N 33/566, G01N 33/68, A61P 37/02
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 22.4.2024
Expires: 29.4.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 16.4.2025
Expires: 29.4.2026
Payer: Árnason Faktor ehf.